Amedisys Operating Margin 2010-2024 | AMED

Current and historical operating margin for Amedisys (AMED) over the last 10 years. The current operating profit margin for Amedisys as of March 31, 2024 is 6.30%.
Amedisys Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2024-03-31 $2.25B $0.15B 6.49%
2023-12-31 $2.24B $0.16B 6.98%
2023-09-30 $2.23B $0.17B 7.54%
2023-06-30 $2.23B $0.17B 7.40%
2023-03-31 $2.23B $0.18B 7.83%
2022-12-31 $2.22B $0.18B 8.14%
2022-09-30 $2.22B $0.18B 8.24%
2022-06-30 $2.22B $0.20B 9.07%
2022-03-31 $2.23B $0.23B 10.38%
2021-12-31 $2.23B $0.25B 11.32%
2021-09-30 $2.23B $0.27B 11.96%
2021-06-30 $2.22B $0.27B 12.25%
2021-03-31 $2.16B $0.24B 11.30%
2020-12-31 $2.11B $0.22B 10.40%
2020-09-30 $2.05B $0.20B 9.71%
2020-06-30 $2.00B $0.18B 9.17%
2020-03-31 $1.98B $0.18B 8.99%
2019-12-31 $1.96B $0.18B 9.10%
2019-09-30 $1.89B $0.17B 9.11%
2019-06-30 $1.81B $0.17B 9.11%
2019-03-31 $1.73B $0.16B 9.42%
2018-12-31 $1.66B $0.16B 9.33%
2018-09-30 $1.63B $0.15B 9.16%
2018-06-30 $1.58B $0.13B 8.34%
2018-03-31 $1.55B $0.09B 5.76%
2017-12-31 $1.51B $0.08B 5.16%
2017-09-30 $1.46B $0.06B 4.24%
2017-06-30 $1.45B $0.05B 3.66%
2017-03-31 $1.44B $0.07B 4.94%
2016-12-31 $1.42B $0.06B 4.01%
2016-09-30 $1.41B $0.06B 4.26%
2016-06-30 $1.37B $0.06B 4.59%
2016-03-31 $1.33B $0.06B 4.60%
2015-12-31 $1.28B $-0.01B -0.63%
2015-09-30 $1.24B $-0.01B -0.80%
2015-06-30 $1.22B $-0.01B -0.90%
2015-03-31 $1.21B $-0.01B -1.16%
2014-12-31 $1.21B $0.02B 1.99%
2014-09-30 $1.21B $-0.00B -0.08%
2014-06-30 $1.21B $-0.17B -14.16%
2014-03-31 $1.22B $-0.18B -14.77%
2013-12-31 $1.25B $-0.16B -12.41%
2013-09-30 $1.29B $-0.30B -23.04%
2013-06-30 $1.35B $-0.13B -9.47%
2013-03-31 $1.40B $-0.12B -8.36%
2012-12-31 $1.44B $-0.11B -7.63%
2012-09-30 $1.42B $0.06B 4.09%
2012-06-30 $1.42B $-0.51B -35.96%
2012-03-31 $1.43B $-0.49B -34.08%
2011-12-31 $1.42B $-0.47B -33.10%
2011-09-30 $1.46B $-0.43B -29.42%
2011-06-30 $1.49B $0.16B 10.92%
2011-03-31 $1.55B $0.18B 11.57%
2010-12-31 $1.60B $0.21B 13.18%
2010-09-30 $1.62B $0.23B 13.99%
2010-06-30 $1.60B $0.25B 15.63%
2010-03-31 $1.56B $0.25B 16.33%
2009-12-31 $1.48B $0.24B 16.11%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $3.184B $2.236B
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $18.408B 11.14
Quest Diagnostics (DGX) United States $16.369B 16.92
DaVita (DVA) United States $12.274B 15.25
Encompass Health (EHC) United States $8.690B 22.25
Chemed (CHE) United States $8.208B 25.44
Elanco Animal Health (ELAN) United States $6.326B 16.41
Option Care Health (OPCH) United States $5.413B 20.49
RadNet (RDNT) United States $4.626B 96.34
Astrana Health (ASTH) United States $2.784B 37.66
Addus HomeCare (ADUS) United States $2.196B 28.43
LifeStance Health (LFST) United States $2.133B 0.00
U.S Physical Therapy (USPH) United States $1.448B 38.74
Pennant (PNTG) United States $0.836B 44.19
Aveanna Healthcare Holdings (AVAH) United States $0.770B 0.00
Atai Life Sciences (ATAI) Germany $0.249B 0.00
Daxor (DXR) United States $0.045B 0.00
ATI Physical Therapy (ATIP) United States $0.026B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.018B 0.00
Ontrak (OTRK) United States $0.014B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Novo Integrated Sciences (NVOS) United States $0.012B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00